Company profile: Immunostep
1.1 - Company Overview
Company description
- Provider of flow chemistry products and services for diagnostic and research applications, including antibodies and conjugates, recombinant proteins, vials, staining solutions, and stability reagents, plus mono- and polyclonal development and peptide production. Offers kits for flow cytometry such as HeMoStep, apoptosis and basophil activation, platelet immunoglobulin and COVID-19 tests, and the ExoStep exosome platform.
Products and services
- ExoStep Platform: Bead-assisted flow cytometry platform that detects and characterizes exosomes, enabling phenotyping of extracellular vesicles for diagnostic and research applications
- COVID-19 Kits: ELISA-based serological assays for diagnosing and monitoring SARS-CoV-2, detecting anti-SARS-CoV-2 antibodies via flow cytometry and ELISA to support immune status tracking
- Basophil Activation Kit: CD63-based flow cytometry kit that determines basophil activation after allergen stimulation, measuring CD63 expression changes for allergy assessment in clinical or research settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Immunostep
Epimeron
HQ: United States
Website
- Description: Provider of gene discovery, deployment, and optimization solutions that support important plant biochemical functions required for maximum product yield.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epimeron company profile →
Decode Genetics
HQ: Iceland
Website
- Description: Provider of biopharmaceutical diagnostic tests for gene variant detection, using population studies to identify human genes linked to common diseases and applying findings to guide candidate drug development; has discovered key genetic risk factors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decode Genetics company profile →
Hexagon Bio
HQ: United States
Website
- Description: Provider of data-driven biotech solutions developing targeted small molecule therapeutics, including drug-target prediction via the TICker algorithm to identify microbial secondary metabolites that inhibit cancer-related proteins; DNA sequencing to build the world's largest database of microbial genomes and metabolites; compound production via the HEx platform using heterologous expression; and ADC payloads from natural products for oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hexagon Bio company profile →
Astute Medical
HQ: United States
Website
- Description: Provider of diagnostic solutions for high-risk medical conditions via identification and validation of protein biomarkers, focused on community and hospital-acquired acute conditions needing rapid diagnosis and risk assessment. Products include BIOFIRE FILMARRAY Torch, VITEK MS, VIDAS BRAHMS PCT, and BACT/ALERT VIRTUO.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astute Medical company profile →
GenoSpace
HQ: United States
Website
- Description: Provider of a precision medicine software platform that makes biomedical data useful and usable, enabling interpretation, analysis, reporting, and collaboration. Offers clinical trial matching using clinical-genomic data, EMR-to-EDC integration to transfer EMR data to clinical trial databases, and study feasibility and site selection tools evaluating enrollment potential and competing trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenoSpace company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Immunostep
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Immunostep
2.2 - Growth funds investing in similar companies to Immunostep
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Immunostep
4.2 - Public trading comparable groups for Immunostep
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →